AR217814A1 - Procedimiento para la preparacion de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)(c1,4)-diazepinas - Google Patents

Procedimiento para la preparacion de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)(c1,4)-diazepinas

Info

Publication number
AR217814A1
AR217814A1 AR265336A AR26533676A AR217814A1 AR 217814 A1 AR217814 A1 AR 217814A1 AR 265336 A AR265336 A AR 265336A AR 26533676 A AR26533676 A AR 26533676A AR 217814 A1 AR217814 A1 AR 217814A1
Authority
AR
Argentina
Prior art keywords
diazepinas
pirido
triazol
phenyl
procedure
Prior art date
Application number
AR265336A
Other languages
English (en)
Spanish (es)
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Application granted granted Critical
Publication of AR217814A1 publication Critical patent/AR217814A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR265336A 1975-11-04 1976-11-03 Procedimiento para la preparacion de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)(c1,4)-diazepinas AR217814A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT837275A AT350056B (de) 1975-11-04 1975-11-04 Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen

Publications (1)

Publication Number Publication Date
AR217814A1 true AR217814A1 (es) 1980-04-30

Family

ID=3604891

Family Applications (3)

Application Number Title Priority Date Filing Date
AR265336A AR217814A1 (es) 1975-11-04 1976-11-03 Procedimiento para la preparacion de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)(c1,4)-diazepinas
AR268053A AR216916A1 (es) 1975-11-04 1977-06-14 Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales
AR268052A AR216915A1 (es) 1975-11-04 1977-06-14 Procedimiento para la preparacion de 1-ceto-6(2-halofenil)-8-halo-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas-2-sustituidas

Family Applications After (2)

Application Number Title Priority Date Filing Date
AR268053A AR216916A1 (es) 1975-11-04 1977-06-14 Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales
AR268052A AR216915A1 (es) 1975-11-04 1977-06-14 Procedimiento para la preparacion de 1-ceto-6(2-halofenil)-8-halo-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas-2-sustituidas

Country Status (30)

Country Link
US (1) US4110455A (fr)
JP (1) JPS5831351B2 (fr)
AR (3) AR217814A1 (fr)
AT (1) AT350056B (fr)
AU (1) AU504228B2 (fr)
BE (1) BE847952A (fr)
CA (1) CA1076111A (fr)
CH (1) CH630920A5 (fr)
CS (1) CS191181B2 (fr)
DD (1) DD128178A5 (fr)
DE (1) DE2649116A1 (fr)
DK (1) DK142324B (fr)
EG (1) EG12280A (fr)
ES (2) ES452971A1 (fr)
FI (1) FI62088C (fr)
FR (1) FR2330404A1 (fr)
GB (1) GB1562800A (fr)
HU (1) HU177422B (fr)
IL (1) IL50816A (fr)
IN (1) IN144289B (fr)
MX (1) MX4284E (fr)
NL (1) NL7612187A (fr)
NO (1) NO146470C (fr)
PL (2) PL118308B1 (fr)
PT (1) PT65787B (fr)
RO (2) RO77294A (fr)
SE (1) SE7612260L (fr)
SU (2) SU667137A3 (fr)
YU (1) YU269176A (fr)
ZA (1) ZA766620B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1185601A (fr) * 1981-02-27 1985-04-16 Walter Hunkeler Imidazodiazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2705039B1 (fr) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Inhibiteurs de bromodomaines et leurs utilisations
EP2721031B1 (fr) 2011-06-17 2016-01-20 Constellation Pharmaceuticals, Inc. Inhibiteurs à bromodomaine et leurs utilisations
WO2013184878A1 (fr) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Inhibiteurs de bromo-domaine de benzo [b] isoxazoloazépines et applications associées
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
DK3157928T3 (da) 2014-06-20 2019-05-20 Constellation Pharmaceuticals Inc Krystallinske former af 2-((4s)-6-(4-chlorphenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT327917B (de) * 1973-04-12 1976-02-25 Degussa Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen
US4039551A (en) * 1976-03-15 1977-08-02 The Upjohn Company 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines

Also Published As

Publication number Publication date
PL113803B1 (en) 1981-01-31
NO763739L (fr) 1977-05-05
JPS5259194A (en) 1977-05-16
ATA837275A (de) 1978-10-15
RO70245A (fr) 1981-06-30
AR216915A1 (es) 1980-02-15
CH630920A5 (de) 1982-07-15
RO77294A (fr) 1982-09-09
BE847952A (fr) 1977-05-03
IL50816A0 (en) 1977-01-31
ES452971A1 (es) 1978-10-16
NO146470B (no) 1982-06-28
PL193439A1 (pl) 1979-07-16
FR2330404B1 (fr) 1979-07-20
FI763158A (fr) 1977-05-05
IN144289B (fr) 1978-04-22
AU1931176A (en) 1978-05-11
YU269176A (en) 1983-02-28
DK142324B (da) 1980-10-13
SU676165A3 (ru) 1979-07-25
ES452969A1 (es) 1977-11-16
DE2649116A1 (de) 1977-05-18
FR2330404A1 (fr) 1977-06-03
FI62088C (fi) 1982-11-10
AT350056B (de) 1979-05-10
NO146470C (no) 1982-10-06
PL118308B1 (en) 1981-09-30
DK497076A (fr) 1977-05-05
CA1076111A (fr) 1980-04-22
DK142324C (fr) 1981-03-02
SE7612260L (sv) 1977-05-05
AU504228B2 (en) 1979-10-04
JPS5831351B2 (ja) 1983-07-05
US4110455A (en) 1978-08-29
FI62088B (fi) 1982-07-30
MX4284E (es) 1982-03-12
SU667137A3 (ru) 1979-06-05
PT65787B (de) 1978-05-10
PT65787A (de) 1976-12-01
HU177422B (en) 1981-10-28
IL50816A (en) 1980-09-16
EG12280A (en) 1978-12-31
CS191181B2 (en) 1979-06-29
DD128178A5 (de) 1977-11-02
AR216916A1 (es) 1980-02-15
NL7612187A (nl) 1977-05-06
ZA766620B (en) 1977-12-28
GB1562800A (en) 1980-03-19

Similar Documents

Publication Publication Date Title
AR215930A1 (es) Procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
MX3591E (es) Procedimiento para la preparacion de derivados de 1,4-dihidropiridina
MX4717E (es) Procedimiento para la preparacion de derivados de pirrolidina
MX4089E (es) Procedimiento mejorado para la preparacion de n-fosfonometilglicina
MX5119E (es) Procedimiento mejorado para la preparacion de derivados de pirimidona
MX4614E (es) Procedimiento mejorado para la preparacion de derivados de pirimidina
MX143488A (es) Procedimiento para la preparacion de resorcinas
MX3744E (es) Procedimiento para la preparacion de derivados de tetrahi--drotieno (3,2-c)-piridina
AR210349A1 (es) Procedimiento para la preparacion de 6-coloro-2(piperacinil)piracina
AR220675A1 (es) Procedimiento para la preparacion de derivados sustituidos de pirido(1,2-a)pirimidinas
AR217814A1 (es) Procedimiento para la preparacion de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)(c1,4)-diazepinas
MX5529E (es) Procedimiento para la preparacion de indolo-(2,3-a)-quinolizidinas
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
MX3932E (es) Procedimiento para la preparacion de 4,5-diaril-2-(tiosustituido) imidazoles
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
DOP1977002589A (es) Procedimiento para la preparacion de nuevas tiazolinas.
MX143639A (es) Procedimiento para la preparacion de compuestos disazoicos tetrarreactivos
MX3878E (es) Procedimiento para preparar derivados de 6-aril-pirrolo (1,2-a) imidazola
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
AR209835A1 (es) Procedimiento para la preparacion de elastasa pancreatica
AR208361A1 (es) Procedimiento para la preparacion de derivados l-piroglutamil-l-histidil-3-alquil-prolinamida
AR215851A1 (es) Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma
MX144201A (es) Procedimiento mejorado para la preparacion de ciclohexanodionas (1,3)
MX3739E (es) Procedimiento para la preparacion de acilamino-penicilinas-6-substituida